{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:22:40Z","timestamp":1778102560395,"version":"3.51.4"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Clostridioides difficile infection (CDI) is one of the most common hospital-acquired infections. Its incidence has increased during the last decade in the community among individuals with no previous risk factors; however, morbidity and mortality are still considered high in elderly patients. Oral Vancomycin and Fidaxomicin are the first lines of treatment for CDI. The systemic bioavailability of oral Vancomycin is thought to be undetectable due to its poor absorption in the gastrointestinal tract; therefore, routine monitoring is not warranted. Only 12 case reports were found in the literature that described adverse reactions associated with oral Vancomycin and its related risk factors. We present a case of a 66-year-old gentleman with severe CDI and acute renal failure who was started on oral Vancomycin upon admission. On day five of treatment, he developed leukocytosis associated with neutrophilia, eosinophilia, and atypical lymphocytes, with no evidence of active infection. Three days later, he developed a pruritic maculopapular rash in more than 50% of his body surface area. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) was ruled out since the patient only had three inclusion criteria for this diagnosis. No clear inciting agent was found. Oral Vancomycin was stopped and supportive treatment was supplied for a presumed Vancomycin-induced allergic reaction. The patient had an excellent response, with complete resolution of the rash and leukocytosis in less than 48 h. By reporting this case, we want to raise awareness among clinicians to remember that, albeit rare, oral Vancomycin can be the cause of adverse drug reactions in patients with severe illnesses.<\/jats:p>","DOI":"10.3390\/idr15020019","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:45:35Z","timestamp":1680151535000},"page":"180-187","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Case of Oral-Vancomycin-Induced Rash in a Patient with Acute Kidney Injury"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-7198","authenticated-orcid":false,"given":"Milena","family":"Cardozo","sequence":"first","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Department of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angadbir S.","family":"Parmar","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Department of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6964-5956","authenticated-orcid":false,"given":"Libardo","family":"Rueda Prada","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Department of Hospital Medicine, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6634-6272","authenticated-orcid":false,"given":"Fnu","family":"Shweta","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA"},{"name":"Department of Infectious Diseases, Mayo Clinic Health System, Eau Claire, WI 54703, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited\u201460 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/00365548.2010.544671","article-title":"Systemic absorption of oral vancomycin in patients with Clostridium difficile infection","volume":"43","author":"Rao","year":"2011","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_5","unstructured":"Patel, S., Preuss, C.V., and Bernice, F. (2022). StatPearls, StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0897190013499521","article-title":"Epidemiology of Clostridium difficile infection","volume":"26","author":"Depestel","year":"2013","journal-title":"J. Pharm. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nurpra.2012.10.007","article-title":"Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications","volume":"9","author":"Juneau","year":"2013","journal-title":"J. Nurse Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jiac.2017.08.004","article-title":"An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency","volume":"23","author":"Yamazaki","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"A2152","DOI":"10.1016\/j.chest.2019.08.2093","article-title":"Systemic Absorption of oral and rectal vancomycin in critically ill patient","volume":"156","author":"Rakocevic","year":"2019","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.1538","article-title":"Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection","volume":"35","author":"Pettit","year":"2015","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4168\/aair.2010.2.2.77","article-title":"Update on the management of antibiotic allergy","volume":"2","author":"Thong","year":"2010","journal-title":"Allergy Asthma Immunol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.7326\/0003-4819-115-5-410","article-title":"Red Man Syndrome after Oral Vancomycin","volume":"115","author":"Killian","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1757-1626-1-111","article-title":"An elderly woman with \u2018Red Man Syndrome\u2019 in association with oral vancomycin therapy: A case report","volume":"1","author":"Bailey","year":"2008","journal-title":"Cases J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nallasivan, M., Maher, F., and Murthy, K. (2009). Rare case of \u201cred man\u201d syndrome in a female patient treated with oral vancomycin for Clostridium difficile diarrhoea. BMJ Case Rep., 2009.","DOI":"10.1136\/bcr.03.2009.1705"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12691\/ajmcr-7-1-5","article-title":"Red Man Syndrome with Oral Vancomycin: A Case Report","volume":"7","author":"Khudyakov","year":"2019","journal-title":"Am. J. Med. Case Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0190-9622(00)90102-6","article-title":"Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency","volume":"42","author":"Klein","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1177\/106002809102501207","article-title":"Oral Vancomycin-Induced Rash: Case Report and Review of the Literature","volume":"25","author":"McCullough","year":"1991","journal-title":"DICP"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/591282","article-title":"Maculopapular Rash Induced by Oral Vancomycin","volume":"47","author":"Osawa","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","first-page":"225","article-title":"A pentad of vancomycin reactions","volume":"9","author":"Shah","year":"2011","journal-title":"Skinmed"},{"key":"ref_21","first-page":"579","article-title":"Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection","volume":"41","author":"Lemire","year":"2012","journal-title":"Infection"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/ijd.12944","article-title":"Vancomycin-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon","volume":"54","author":"Choudhry","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2169\/internalmedicine.54.4026","article-title":"Continuous Administration of Vancomycin through a Long Intestinal Tube for Clostridium difficile Infection","volume":"54","author":"Mizumura","year":"2015","journal-title":"Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/0897190016668437","article-title":"Hypersensitivity Reaction Following Administration of Low-Dose Oral Vancomycin for the Treatment of Clostridium difficile in a Patient with Normal Renal Function","volume":"30","author":"Baumgartner","year":"2016","journal-title":"J. Pharm. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13223-018-0293-2","article-title":"Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: Case report and review of the literature","volume":"14","author":"Barron","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/15\/2\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:06:51Z","timestamp":1760123211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/15\/2\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["idr15020019"],"URL":"https:\/\/doi.org\/10.3390\/idr15020019","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]}}}